JOURNAL/mgres/04.03/01612956-990000000-00073/figure1/v/2026-01-23T123057Z/r/image-tiff Defects in myelination impair nerve impulse conduction and functional connectivity, which could lead to cognitive, behavioral and motor deficits in various neurological disorders. Adequate oxygen delivery is vital for brain development, while hypoxia in newborns tends to result in developmental deficiencies in myelination of the brain. The disruption of oligodendrocytes and their progenitor cells caused by hypoxia has been well researched. Nonetheless, the impairing dynamic myelination process is still unclear. Utilizing zebrafish as a model, we established hypoxia via cobalt chloride exposure or low oxygen (8%) incubation. Hypoxia significantly reduced oligodendrocyte progenitor cell numbers in the dorsal spinal cord, impaired migration velocity and suppressed proliferation. Myelination deficits were evident through decreased myelin sheath segment intensity in Tg(MBP:eGFP-CAAX) larvae. Time-lapse imaging revealed compromised dynamic myelination by individual oligodendrocytes under hypoxia, with fewer sheaths and reduced extension rates. Mechanistically, hypoxia elevated reactive oxygen species levels and disrupted mitochondrial membrane potential in cultured rat oligodendrocyte progenitor cells. Nanoscale magnesium hydride, a hydrogen-releasing agent, attenuated these effects. In vivo, magnesium hydride treatment rescued oligodendrocyte progenitor cell numbers and enhanced myelinogenesis capacity in hypoxic zebrafish. These findings demonstrate that magnesium hydride mitigates hypoxia-induced oxidative stress and mitochondrial dysfunction, thereby alleviating myelination deficits.
{"title":"Nanoscale magnesium hydride alleviates hypoxia-induced myelination deficits in zebrafish.","authors":"Jia-Lin Li, Qiang Chen, Zheng-Hao Li, Dao-Jie Xu, Cheng He, Peng Liu","doi":"10.4103/mgr.MEDGASRES-D-25-00104","DOIUrl":"https://doi.org/10.4103/mgr.MEDGASRES-D-25-00104","url":null,"abstract":"<p><p>JOURNAL/mgres/04.03/01612956-990000000-00073/figure1/v/2026-01-23T123057Z/r/image-tiff Defects in myelination impair nerve impulse conduction and functional connectivity, which could lead to cognitive, behavioral and motor deficits in various neurological disorders. Adequate oxygen delivery is vital for brain development, while hypoxia in newborns tends to result in developmental deficiencies in myelination of the brain. The disruption of oligodendrocytes and their progenitor cells caused by hypoxia has been well researched. Nonetheless, the impairing dynamic myelination process is still unclear. Utilizing zebrafish as a model, we established hypoxia via cobalt chloride exposure or low oxygen (8%) incubation. Hypoxia significantly reduced oligodendrocyte progenitor cell numbers in the dorsal spinal cord, impaired migration velocity and suppressed proliferation. Myelination deficits were evident through decreased myelin sheath segment intensity in Tg(MBP:eGFP-CAAX) larvae. Time-lapse imaging revealed compromised dynamic myelination by individual oligodendrocytes under hypoxia, with fewer sheaths and reduced extension rates. Mechanistically, hypoxia elevated reactive oxygen species levels and disrupted mitochondrial membrane potential in cultured rat oligodendrocyte progenitor cells. Nanoscale magnesium hydride, a hydrogen-releasing agent, attenuated these effects. In vivo, magnesium hydride treatment rescued oligodendrocyte progenitor cell numbers and enhanced myelinogenesis capacity in hypoxic zebrafish. These findings demonstrate that magnesium hydride mitigates hypoxia-induced oxidative stress and mitochondrial dysfunction, thereby alleviating myelination deficits.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.4103/mgr.MEDGASRES-D-25-00063
Lifen Lu, Lijia Zhao, Yujie Xie, Li Wang, Yuxiu Ji, Xi Luo, Chi Zhang
JOURNAL/mgres/04.03/01612956-990000000-00074/figure1/v/2026-01-23T103409Z/r/image-tiff As a non-invasive and drug-free treatment method, hyperbaric oxygen therapy has been applied in cerebrovascular accidents to improve cerebral hypoxia, reduce ischemia-reperfusion injury following stroke and promote neural repair. However, its clinical efficacy remains controversial. This work aims to analyze the progress of research on the role of hyperbaric oxygen in stroke through bibliometric methods and takes relevant literature from the Web of Science core database from 2007 to December 31, 2024. The results showed that from 2007 to the present, the annual number of English publications in this field has shown a fluctuating but gradual upward trend, with the peak in publication volume occurring in 2015. China is in a leading position in this field, but there is still a lack of international cooperation and high-impact journal articles from Chinese institutions and researchers. The top five keywords were "hyperbaric oxygen" (84 occurrences), "stroke" (46 occurrences), "hyperbaric oxygen therapy" (45 occurrences), "focal cerebral ischemia" (27 occurrences), and "cerebral ischemia" (26 occurrences). A total of 13 major research areas were identified, including #0 stem cells, #1 hyperbaric oxygen, #2 perfusion, #3 EPR oximetry, #4 tPA, #5 rehabilitation, #6 acute stroke, #7 TBI, #8 stroke medicine, #9 hyperbaric oxygen preconditioning, #10 preconditioning, #11 ischemia-reperfusion injury, and #12 hyperbaric. At present, there are relatively few clinical trials registered on hyperbaric oxygen therapy for the treatment of stroke. Due to the fact that the effectiveness of hyperbaric oxygen therapy depends on the type and timing of stroke, there is currently no unified standard for the optimal timing and duration of hyperbaric oxygen therapy. Overall, hyperbaric oxygen therapy is safe and reliable, with most adverse reactions being mild and reversible. In summary, hyperbaric oxygen therapy has significant neuroprotective and functional recovery potential in stroke patients.
高压氧治疗作为一种无创、无药物的治疗方法,已被应用于脑血管意外中,改善脑缺氧,减轻脑卒中后缺血再灌注损伤,促进神经修复。然而,其临床疗效仍存在争议。本工作旨在通过文献计量学方法分析高压氧在脑卒中中的作用的研究进展,并从2007年至2024年12月31日的Web of Science核心数据库中获取相关文献。结果表明,从2007年至今,该领域的年度英文出版物数量呈波动但逐渐上升的趋势,出版物量在2015年达到峰值。中国在这一领域处于领先地位,但仍然缺乏国际合作和来自中国机构和研究人员的高影响力期刊文章。排名前五的关键词是“高压氧”(84次)、“中风”(46次)、“高压氧治疗”(45次)、“局灶性脑缺血”(27次)和“脑缺血”(26次)。共确定了13个主要研究领域,包括#0干细胞,#1高压氧,#2灌注,#3 EPR血氧测定,#4 tPA, #5康复,#6急性卒中,#7 TBI, #8卒中医学,#9高压氧预处理,#10预处理,#11缺血再灌注损伤,#12高压氧。目前,关于高压氧治疗脑卒中的临床试验比较少。由于高压氧治疗的效果取决于脑卒中的类型和时机,目前对高压氧治疗的最佳时机和持续时间没有统一的标准。总的来说,高压氧治疗是安全可靠的,大多数不良反应是轻微和可逆的。综上所述,高压氧治疗对脑卒中患者具有显著的神经保护和功能恢复潜力。
{"title":"Research hotspots and trends of hyperbaric oxygen therapy in stroke: bibliometrics and visual analysis.","authors":"Lifen Lu, Lijia Zhao, Yujie Xie, Li Wang, Yuxiu Ji, Xi Luo, Chi Zhang","doi":"10.4103/mgr.MEDGASRES-D-25-00063","DOIUrl":"https://doi.org/10.4103/mgr.MEDGASRES-D-25-00063","url":null,"abstract":"<p><p>JOURNAL/mgres/04.03/01612956-990000000-00074/figure1/v/2026-01-23T103409Z/r/image-tiff As a non-invasive and drug-free treatment method, hyperbaric oxygen therapy has been applied in cerebrovascular accidents to improve cerebral hypoxia, reduce ischemia-reperfusion injury following stroke and promote neural repair. However, its clinical efficacy remains controversial. This work aims to analyze the progress of research on the role of hyperbaric oxygen in stroke through bibliometric methods and takes relevant literature from the Web of Science core database from 2007 to December 31, 2024. The results showed that from 2007 to the present, the annual number of English publications in this field has shown a fluctuating but gradual upward trend, with the peak in publication volume occurring in 2015. China is in a leading position in this field, but there is still a lack of international cooperation and high-impact journal articles from Chinese institutions and researchers. The top five keywords were \"hyperbaric oxygen\" (84 occurrences), \"stroke\" (46 occurrences), \"hyperbaric oxygen therapy\" (45 occurrences), \"focal cerebral ischemia\" (27 occurrences), and \"cerebral ischemia\" (26 occurrences). A total of 13 major research areas were identified, including #0 stem cells, #1 hyperbaric oxygen, #2 perfusion, #3 EPR oximetry, #4 tPA, #5 rehabilitation, #6 acute stroke, #7 TBI, #8 stroke medicine, #9 hyperbaric oxygen preconditioning, #10 preconditioning, #11 ischemia-reperfusion injury, and #12 hyperbaric. At present, there are relatively few clinical trials registered on hyperbaric oxygen therapy for the treatment of stroke. Due to the fact that the effectiveness of hyperbaric oxygen therapy depends on the type and timing of stroke, there is currently no unified standard for the optimal timing and duration of hyperbaric oxygen therapy. Overall, hyperbaric oxygen therapy is safe and reliable, with most adverse reactions being mild and reversible. In summary, hyperbaric oxygen therapy has significant neuroprotective and functional recovery potential in stroke patients.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146030079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.4103/mgr.MEDGASRES-D-25-00227
Anish Patel, Deepak Batura
Fournier's gangrene is a rare, rapidly progressive necrotizing soft tissue infection of the genitals and perineum that continues to carry a high mortality rate. Hyperbaric oxygen therapy has been proposed as an adjunctive treatment, but its efficacy remains uncertain. We conducted a systematic review and meta-analysis of studies comparing hyperbaric oxygen therapy with standard care in adults with Fournier's gangrene. A comprehensive search of PubMed/MEDLINE, Embase, Cochrane Library, Scopus, and Web of Science identified thirteen retrospective studies including 322 patients treated with hyperbaric oxygen therapy and 366 controls. Hyperbaric oxygen therapy was associated with a significantly lower mortality rate compared with control groups. Secondary outcomes, including hospital length of stay and number of debridements, showed inconsistent results and did not differ significantly between groups. These findings suggest that hyperbaric oxygen therapy may reduce mortality in patients with Fournier's gangrene and could be considered as an adjunctive therapy. FactsA meta-analysis demonstrated hyperbaric oxygen therapy reduces the relative risk of death in patients suffering from Fournier's gangrene.The present study has revealed no statistically significant differences in terms of hospital length of stay or the number of surgical debridements in patients with Fournier's gangrene between the hyperbaric oxygen therapy and control groups.The extant evidence supports the use of hyperbaric oxygen therapy as an ancillary measure of Fournier's gangrene following prompt surgical debridement and antimicrobial therapy, rather than as a primary treatment modality.Open questionsWhat are the optimal hyperbaric oxygen treatment protocols (pressure, duration, number of sessions) for patients with Fournier's gangrene?Which patient subgroups (e.g. comorbidities, infection severity) derive the most benefit from hyperbaric oxygen therapy?How does hyperbaric oxygen therapy affect resource utilization and cost-effectiveness, particularly in healthcare systems with limited hyperbaric infrastructure?
富尼耶坏疽是一种罕见的,快速进展的坏死性软组织感染的生殖器和会阴,仍然具有高死亡率。高压氧治疗已被提出作为辅助治疗,但其疗效仍不确定。我们对成人富尼耶坏疽患者高压氧治疗与标准治疗的比较研究进行了系统回顾和荟萃分析。综合检索PubMed/MEDLINE、Embase、Cochrane Library、Scopus和Web of Science,确定了13项回顾性研究,包括322例高压氧治疗患者和366例对照。与对照组相比,高压氧治疗与显著降低的死亡率相关。次要结局,包括住院时间和清创次数,显示出不一致的结果,两组之间没有显著差异。这些发现表明高压氧治疗可以降低富尼耶坏疽患者的死亡率,可以考虑作为一种辅助治疗。FactsA荟萃分析显示,高压氧治疗可降低富尼耶坏疽患者的相对死亡风险。本研究显示高压氧治疗组与对照组在富尼耶坏疽患者住院时间或手术清创次数方面无统计学差异。现有证据支持高压氧治疗作为富尼耶坏疽的辅助措施,在及时手术清创和抗菌治疗后,而不是作为主要治疗方式。开放性问题:富尼耶坏疽患者的最佳高压氧治疗方案(压力、持续时间、次数)是什么?哪些患者亚组(如合并症、感染严重程度)从高压氧治疗中获益最大?高压氧治疗如何影响资源利用和成本效益,特别是在高压氧基础设施有限的医疗保健系统中?
{"title":"Hyperbaric oxygen therapy and Fournier's gangrene: a systematic review and meta-analysis.","authors":"Anish Patel, Deepak Batura","doi":"10.4103/mgr.MEDGASRES-D-25-00227","DOIUrl":"https://doi.org/10.4103/mgr.MEDGASRES-D-25-00227","url":null,"abstract":"<p><p>Fournier's gangrene is a rare, rapidly progressive necrotizing soft tissue infection of the genitals and perineum that continues to carry a high mortality rate. Hyperbaric oxygen therapy has been proposed as an adjunctive treatment, but its efficacy remains uncertain. We conducted a systematic review and meta-analysis of studies comparing hyperbaric oxygen therapy with standard care in adults with Fournier's gangrene. A comprehensive search of PubMed/MEDLINE, Embase, Cochrane Library, Scopus, and Web of Science identified thirteen retrospective studies including 322 patients treated with hyperbaric oxygen therapy and 366 controls. Hyperbaric oxygen therapy was associated with a significantly lower mortality rate compared with control groups. Secondary outcomes, including hospital length of stay and number of debridements, showed inconsistent results and did not differ significantly between groups. These findings suggest that hyperbaric oxygen therapy may reduce mortality in patients with Fournier's gangrene and could be considered as an adjunctive therapy. FactsA meta-analysis demonstrated hyperbaric oxygen therapy reduces the relative risk of death in patients suffering from Fournier's gangrene.The present study has revealed no statistically significant differences in terms of hospital length of stay or the number of surgical debridements in patients with Fournier's gangrene between the hyperbaric oxygen therapy and control groups.The extant evidence supports the use of hyperbaric oxygen therapy as an ancillary measure of Fournier's gangrene following prompt surgical debridement and antimicrobial therapy, rather than as a primary treatment modality.Open questionsWhat are the optimal hyperbaric oxygen treatment protocols (pressure, duration, number of sessions) for patients with Fournier's gangrene?Which patient subgroups (e.g. comorbidities, infection severity) derive the most benefit from hyperbaric oxygen therapy?How does hyperbaric oxygen therapy affect resource utilization and cost-effectiveness, particularly in healthcare systems with limited hyperbaric infrastructure?</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146030345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15DOI: 10.4103/mgr.MEDGASRES-D-25-00242
Frank Keppler, Daniela Polag, Moritz Schroll, Mihaly Boros
{"title":"Beyond climate: the emerging physiological roles of methane and nitrous oxide.","authors":"Frank Keppler, Daniela Polag, Moritz Schroll, Mihaly Boros","doi":"10.4103/mgr.MEDGASRES-D-25-00242","DOIUrl":"https://doi.org/10.4103/mgr.MEDGASRES-D-25-00242","url":null,"abstract":"","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-04-29DOI: 10.4103/mgr.MEDGASRES-D-25-00026
Hao Ke
{"title":"Progress in the clinical application of heliox.","authors":"Hao Ke","doi":"10.4103/mgr.MEDGASRES-D-25-00026","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00026","url":null,"abstract":"","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"15 4","pages":"546-547"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12124710/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-04-29DOI: 10.4103/mgr.MEDGASRES-D-24-00158
Yi Yang, Kangrong Ma, Shun Li, Tianqing Xiong
Vascular dementia is a highly heterogeneous neurodegenerative disorder induced by a variety of factors. Currently, there are no definitive treatments for the cognitive dysfunction associated with vascular dementia. However, early detection and preventive measures have proven effective in reducing the risk of onset and improving patient prognosis. Nitric oxide plays an integral role in various physiological and pathological processes within the central nervous system. In recent years, nitric oxide has been implicated in the regulation of synaptic plasticity and has emerged as a crucial factor in the pathophysiology of vascular dementia. At different stages of vascular dementia, nitric oxide levels and bioavailability undergo dynamic alterations, with a marked reduction in the later stages, which significantly contributes to the cognitive deficits associated with the disease. This review provides a comprehensive review of the emerging role of nitric oxide in the physiological and pathological processes underlying vascular dementia, focusing on its effects on synaptic dysfunction, neuroinflammation, oxidative stress, and blood‒brain barrier integrity. Furthermore, we suggest that targeting the nitric oxide soluble guanylate cyclase-cyclic guanosine monophosphate pathway through specific therapeutic strategies may offer a novel approach for treating vascular dementia, potentially improving both cognitive function and patient prognosis. The review contributes to a better understanding of the multifaceted role of nitric oxide in vascular dementia and to offering insights into future therapeutic interventions.
{"title":"Multifaceted role of nitric oxide in vascular dementia.","authors":"Yi Yang, Kangrong Ma, Shun Li, Tianqing Xiong","doi":"10.4103/mgr.MEDGASRES-D-24-00158","DOIUrl":"10.4103/mgr.MEDGASRES-D-24-00158","url":null,"abstract":"<p><p>Vascular dementia is a highly heterogeneous neurodegenerative disorder induced by a variety of factors. Currently, there are no definitive treatments for the cognitive dysfunction associated with vascular dementia. However, early detection and preventive measures have proven effective in reducing the risk of onset and improving patient prognosis. Nitric oxide plays an integral role in various physiological and pathological processes within the central nervous system. In recent years, nitric oxide has been implicated in the regulation of synaptic plasticity and has emerged as a crucial factor in the pathophysiology of vascular dementia. At different stages of vascular dementia, nitric oxide levels and bioavailability undergo dynamic alterations, with a marked reduction in the later stages, which significantly contributes to the cognitive deficits associated with the disease. This review provides a comprehensive review of the emerging role of nitric oxide in the physiological and pathological processes underlying vascular dementia, focusing on its effects on synaptic dysfunction, neuroinflammation, oxidative stress, and blood‒brain barrier integrity. Furthermore, we suggest that targeting the nitric oxide soluble guanylate cyclase-cyclic guanosine monophosphate pathway through specific therapeutic strategies may offer a novel approach for treating vascular dementia, potentially improving both cognitive function and patient prognosis. The review contributes to a better understanding of the multifaceted role of nitric oxide in vascular dementia and to offering insights into future therapeutic interventions.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"15 4","pages":"496-506"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12124705/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-04-29DOI: 10.4103/mgr.MEDGASRES-D-24-00153
Bang Liu, Jin Wang, Lvjun Liu, Mengmei Lv, Dai Zhou, Min Li
Hyperbaric oxygen therapy has emerged as a potential adjunctive treatment for male infertility, as it targets various sperm abnormalities and improves fertility outcomes. This systematic review and meta-analysis synthesized data from randomized controlled trials to evaluate the efficacy of hyperbaric oxygen therapy in treating male infertility. A comprehensive literature search identified nine eligible studies, which were assessed for quality using the Jadad scale and analyzed for heterogeneity. The meta-analysis revealed significant improvements in sperm survival, density, morphology, normal sperm rates, and motility following hyperbaric oxygen therapy, with an increased clinical pregnancy rate. Subgroup analyses based on infertility etiology and treatment duration further elucidated the heterogeneity of male infertility stemming from the etiology of infertility. Despite the high robustness of the meta-analysis results, the study is limited by the small number of included trials and potential publication bias. In conclusion, when combined with conventional treatments, hyperbaric oxygen therapy significantly enhances sperm parameters and fertility, underscoring its role as an effective adjunctive therapy for male infertility.
{"title":"Hyperbaric oxygen therapy for male infertility: a systematic review and meta-analysis on improving sperm quality and fertility outcomes.","authors":"Bang Liu, Jin Wang, Lvjun Liu, Mengmei Lv, Dai Zhou, Min Li","doi":"10.4103/mgr.MEDGASRES-D-24-00153","DOIUrl":"10.4103/mgr.MEDGASRES-D-24-00153","url":null,"abstract":"<p><p>Hyperbaric oxygen therapy has emerged as a potential adjunctive treatment for male infertility, as it targets various sperm abnormalities and improves fertility outcomes. This systematic review and meta-analysis synthesized data from randomized controlled trials to evaluate the efficacy of hyperbaric oxygen therapy in treating male infertility. A comprehensive literature search identified nine eligible studies, which were assessed for quality using the Jadad scale and analyzed for heterogeneity. The meta-analysis revealed significant improvements in sperm survival, density, morphology, normal sperm rates, and motility following hyperbaric oxygen therapy, with an increased clinical pregnancy rate. Subgroup analyses based on infertility etiology and treatment duration further elucidated the heterogeneity of male infertility stemming from the etiology of infertility. Despite the high robustness of the meta-analysis results, the study is limited by the small number of included trials and potential publication bias. In conclusion, when combined with conventional treatments, hyperbaric oxygen therapy significantly enhances sperm parameters and fertility, underscoring its role as an effective adjunctive therapy for male infertility.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"15 4","pages":"529-534"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12124701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144035129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-04-29DOI: 10.4103/mgr.MEDGASRES-D-25-00017
Karol Jackowski
{"title":"Benefits from nuclear magnetic resonance studies of molecules in the gas-phase.","authors":"Karol Jackowski","doi":"10.4103/mgr.MEDGASRES-D-25-00017","DOIUrl":"10.4103/mgr.MEDGASRES-D-25-00017","url":null,"abstract":"","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"15 4","pages":"544-545"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12124707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-04-29DOI: 10.4103/mgr.MEDGASRES-D-24-00144
Victoria Zaborova, Elena Budanova, Kira Kryuchkova, Vitaly Rybakov, Dmitry Shestakov, Aleksey Isaikin, Dmitry Romanov, Maxim Churyukanov, Natalia Vakhnina, Vladimir Zakharov, Ivan Isaikin, Marina Kinkulkina
Numerous physiological processes in the human skin are mediated by nitric oxide, a gaseous signalling molecule. Almost every type of skin cell may produce nitric oxide, it is possible to generate nitric oxide without the need of enzymes. Nitric oxide plays a crucial role in regulating apoptosis, keratinocyte differentiation and proliferation, the protective properties of the epidermal barrier, and the structure and functions of the microcirculatory bed. Nitric oxide is involved in immunological and inflammatory responses, hair growth regulation, and wound healing processes. It mediates ultraviolet-induced processes such as erythema and edema development and participates in melanogenesis. Furthermore, the ability of nitric oxide to bind reactive oxygen species and prevent lipid peroxidation gives it antioxidant qualities. This coordinated action of nitric oxide on gene expression and membrane integrity effectively protects cells from ultraviolet A-induced apoptosis and necrosis. Furthermore, nitric oxide can be considered as a molecule that inhibits the development of cancer and photoaging. It directly harms microorganisms and indirectly activates the immune system, exhibiting antibacterial, antiviral, and antifungal qualities. Notably, nitric oxide is effective against antibiotics-resistant bacteria. All of the aforementioned findings suggest that nitric oxide is a gaseous mediator that can protect skin function.
{"title":"Nitric oxide: a gas transmitter in healthy and diseased skin.","authors":"Victoria Zaborova, Elena Budanova, Kira Kryuchkova, Vitaly Rybakov, Dmitry Shestakov, Aleksey Isaikin, Dmitry Romanov, Maxim Churyukanov, Natalia Vakhnina, Vladimir Zakharov, Ivan Isaikin, Marina Kinkulkina","doi":"10.4103/mgr.MEDGASRES-D-24-00144","DOIUrl":"10.4103/mgr.MEDGASRES-D-24-00144","url":null,"abstract":"<p><p>Numerous physiological processes in the human skin are mediated by nitric oxide, a gaseous signalling molecule. Almost every type of skin cell may produce nitric oxide, it is possible to generate nitric oxide without the need of enzymes. Nitric oxide plays a crucial role in regulating apoptosis, keratinocyte differentiation and proliferation, the protective properties of the epidermal barrier, and the structure and functions of the microcirculatory bed. Nitric oxide is involved in immunological and inflammatory responses, hair growth regulation, and wound healing processes. It mediates ultraviolet-induced processes such as erythema and edema development and participates in melanogenesis. Furthermore, the ability of nitric oxide to bind reactive oxygen species and prevent lipid peroxidation gives it antioxidant qualities. This coordinated action of nitric oxide on gene expression and membrane integrity effectively protects cells from ultraviolet A-induced apoptosis and necrosis. Furthermore, nitric oxide can be considered as a molecule that inhibits the development of cancer and photoaging. It directly harms microorganisms and indirectly activates the immune system, exhibiting antibacterial, antiviral, and antifungal qualities. Notably, nitric oxide is effective against antibiotics-resistant bacteria. All of the aforementioned findings suggest that nitric oxide is a gaseous mediator that can protect skin function.</p>","PeriodicalId":18559,"journal":{"name":"Medical Gas Research","volume":"15 4","pages":"520-528"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12124702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}